Literature DB >> 31056725

Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study.

Barbara Ruaro1, Stefano Soldano2, Vanessa Smith3,4,5, Sabrina Paolino2, Paola Contini6, Paola Montagna2, Carmen Pizzorni2, Andrea Casabella2, Samuele Tardito2, Alberto Sulli2, Maurizio Cutolo2.   

Abstract

The objective is to detect any possible correlation between the modified Rodnan skin score (mRSS) and dermal thickness (DT) measured by skin high-frequency ultrasound (US) and the percentage of circulating fibrocytes in patients with limited cutaneous systemic sclerosis (lcSSc). Eight lcSSc patients and five healthy subjects (control group, CNT) were enrolled. The skin involvement was evaluated by mRSS and US (18 and 22 MHz probes) in all 13 subjects in the 17 standard skin areas evaluated by mRss. Circulating fibrocytes were isolated from the peripheral blood mononuclear cells (PBMCs) of all lcSSc patients and the CNT group to analyze their percentage at baseline time (T0) when the experiments started with PBMCs' isolation and collection and after 8 days of culture (T8). Non-parametric tests were used for the statistical analysis. A positive correlation between the percentage of circulating fibrocytes at T0, mRSS (p = 0.04 r = 0.96), and DT-US, evaluated by the 22 MHz and the 18 MHz probes (p = 0.03, r = 0.66 and p = 0.05, r = 0.52, respectively), was observed in lcSSc patients. Conversely, at T8, there was no correlation (p > 0.05) between these parameters in lcSSc group. In the CNT group, no correlations between mRSS or DT-US and the percentage of circulating fibrocytes were observed both at T0 and T8. The study shows the presence of a significant relationship between the percentage of circulating fibrocytes and DT, as evidenced by both mRSS and US, in limited cutaneus SSc. This observation may well suggest the reasonable hypothesis of a crucial contribution of circulating fibrocytes to skin fibrosis progression, which might be considered as further biomarkers.

Entities:  

Keywords:  Fibrocytes; High-frequency ultrasound; Modified Rodnan skin score; Systemic sclerosis

Mesh:

Substances:

Year:  2019        PMID: 31056725     DOI: 10.1007/s00296-019-04315-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  44 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Peripheral blood fibrocytes: differentiation pathway and migration to wound sites.

Authors:  R Abe; S C Donnelly; T Peng; R Bucala; C N Metz
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

3.  Seventeen-point dermal ultrasound scoring system--a reliable measure of skin thickness in patients with systemic sclerosis.

Authors:  T L Moore; M Lunt; B McManus; M E Anderson; A L Herrick
Journal:  Rheumatology (Oxford)       Date:  2003-07-16       Impact factor: 7.580

4.  CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.

Authors:  Bethany B Moore; Jill E Kolodsick; Victor J Thannickal; Kenneth Cooke; Thomas A Moore; Cory Hogaboam; Carol A Wilke; Galen B Toews
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

5.  Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow.

Authors:  Luca Mori; Alberto Bellini; Martin A Stacey; Matthias Schmidt; Sabrina Mattoli
Journal:  Exp Cell Res       Date:  2004-12-08       Impact factor: 3.905

6.  Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.

Authors:  M Cutolo; A Sulli; C Pizzorni; S Accardo
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

7.  The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis.

Authors:  László Czirják; Zoltán Nagy; Martin Aringer; Gabriela Riemekasten; Marco Matucci-Cerinic; Daniel E Furst
Journal:  Ann Rheum Dis       Date:  2007-01-18       Impact factor: 19.103

8.  Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients.

Authors:  A Sulli; M E Secchi; C Pizzorni; M Cutolo
Journal:  Ann Rheum Dis       Date:  2007-11-23       Impact factor: 19.103

9.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.

Authors:  Roderick J Phillips; Marie D Burdick; Kurt Hong; Marin A Lutz; Lynne A Murray; Ying Ying Xue; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

10.  Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma.

Authors:  R Russo; H Medbury; A Guiffre; H Englert; N Manolios
Journal:  Clin Rheumatol       Date:  2006-10-24       Impact factor: 3.650

View more
  13 in total

1.  Catalpol Attenuates Pulmonary Fibrosis by Inhibiting Ang II/AT1 and TGF-β/Smad-Mediated Epithelial Mesenchymal Transition.

Authors:  Qun Yu; Dewei Zhu; Yang Zou; Kai Wang; Peili Rao; Yunhui Shen
Journal:  Front Med (Lausanne)       Date:  2022-05-24

Review 2.  The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients.

Authors:  Barbara Ruaro; Marco Confalonieri; Francesco Salton; Barbara Wade; Elisa Baratella; Pietro Geri; Paola Confalonieri; Metka Kodric; Marco Biolo; Cosimo Bruni
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-23

3.  Tentative Peptide‒Lipid Bilayer Models Elucidating Molecular Behaviors and Interactions Driving Passive Cellular Uptake of Collagen-Derived Small Peptides.

Authors:  Pathomwat Wongrattanakamon; Wipawadee Yooin; Busaban Sirithunyalug; Piyarat Nimmanpipug; Supat Jiranusornkul
Journal:  Molecules       Date:  2021-01-29       Impact factor: 4.411

Review 4.  The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis.

Authors:  Barbara Ruaro; Tania Santiago; Michael Hughes; Gemma Lepri; Gabriele Poillucci; Elisa Baratella; Francesco Salton; Marco Confalonieri
Journal:  Open Access Rheumatol       Date:  2021-04-28

Review 5.  Chronic Thromboembolic Pulmonary Hypertension: An Update.

Authors:  Barbara Ruaro; Elisa Baratella; Gaetano Caforio; Paola Confalonieri; Barbara Wade; Cristina Marrocchio; Pietro Geri; Riccardo Pozzan; Alessia Giovanna Andrisano; Maria Assunta Cova; Maurizio Cortale; Marco Confalonieri; Francesco Salton
Journal:  Diagnostics (Basel)       Date:  2022-01-19

Review 6.  Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis.

Authors:  Theodoros-Ioannis Papadimitriou; Arjan van Caam; Peter M van der Kraan; Rogier M Thurlings
Journal:  Biomedicines       Date:  2022-01-29

7.  Velvet Antler Peptides Reduce Scarring via Inhibiting the TGF-β Signaling Pathway During Wound Healing.

Authors:  Guokun Zhang; Dongxu Wang; Jing Ren; Hongmei Sun; Jiping Li; Shengnan Wang; Liyan Shi; Zhen Wang; Mengjie Yao; Haiping Zhao; Chunyi Li
Journal:  Front Med (Lausanne)       Date:  2022-01-21

Review 8.  The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung.

Authors:  Barbara Ruaro; Francesco Salton; Luca Braga; Barbara Wade; Paola Confalonieri; Maria Concetta Volpe; Elisa Baratella; Serena Maiocchi; Marco Confalonieri
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

Review 9.  High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?

Authors:  Barbara Ruaro; Elisa Baratella; Paola Confalonieri; Marco Confalonieri; Fabio Giuseppe Vassallo; Barbara Wade; Pietro Geri; Riccardo Pozzan; Gaetano Caforio; Cristina Marrocchio; Maria Assunta Cova; Francesco Salton
Journal:  Diagnostics (Basel)       Date:  2021-12-07

Review 10.  An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients.

Authors:  Barbara Ruaro; Francesco Salton; Elisa Baratella; Paola Confalonieri; Pietro Geri; Riccardo Pozzan; Chiara Torregiani; Roberta Bulla; Marco Confalonieri; Marco Matucci-Cerinic; Michael Hughes
Journal:  Diagnostics (Basel)       Date:  2022-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.